Where is the role for Antegrade dissection reentry?
Elliot Smith, London, Great Britain
11th Experts Live CTO
The annual Euro CTO meeting
September 13th –14th, 2019 - Berlin, Germany
27. SYMPTOMS
VIABILITY +/- ISCHAEMIA
Could this approach expand the range of indications?
TYPICAL
10% >20%0%
ATYPICAL
SEVERE
ABSENT
CONSISTENT
DECISION CTO
DECISION CTO
28. Successful CTO PCI – Barriers to adoption ADR Training
‘I could but I won’t
‘I can’t but I should
33. Control the space?
• Use of CrossBoss for SMALL blunt dissection
• Preparation - to reduce time between microcatheter
exchanges (e.g. CrossBoss to Stingray)
• Guide Extension / Trapliner
34. Innovation, Iteration, and Evolution
• Size / deliverability – Stingray LP / 7F delivery
• Adjunctive techniques / technologies
– SR wire vs. Hornet 14
– Guide X
– Facilitated ADR
39. What ADR is?
• An enabling technique
• Complementary to other approaches
• Sits within an algorithmic approach
• Up to 20% contemporary cases
40. What ADR isn’t?
• Religion – you don’t need to believe in it
• Dangerous – you are already operating in a high risk
environment
• A last resort when all else fails – success dependent
on appropriate anatomical selection / rules of
engagement